NO20044531L - Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom - Google Patents
Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdomInfo
- Publication number
- NO20044531L NO20044531L NO20044531A NO20044531A NO20044531L NO 20044531 L NO20044531 L NO 20044531L NO 20044531 A NO20044531 A NO 20044531A NO 20044531 A NO20044531 A NO 20044531A NO 20044531 L NO20044531 L NO 20044531L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- medicaments
- aralkylsulfonamides
- imidazolinylmethyl
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37470002P | 2002-04-23 | 2002-04-23 | |
| US37877502P | 2002-05-08 | 2002-05-08 | |
| PCT/EP2003/003904 WO2003091236A1 (en) | 2002-04-23 | 2003-04-15 | Imidazolinylmethyl aralkylsulfonamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20044531L true NO20044531L (no) | 2004-11-19 |
Family
ID=29273005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20044531A NO20044531L (no) | 2002-04-23 | 2004-10-21 | Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6756395B2 (ru) |
| EP (1) | EP1501817A1 (ru) |
| JP (1) | JP4362379B2 (ru) |
| KR (1) | KR100696561B1 (ru) |
| CN (1) | CN1296365C (ru) |
| AR (1) | AR039319A1 (ru) |
| AU (1) | AU2003227623B2 (ru) |
| BR (1) | BR0309668A (ru) |
| CA (1) | CA2483345C (ru) |
| HK (1) | HK1080463A1 (ru) |
| HR (1) | HRP20040951A2 (ru) |
| IL (1) | IL164676A0 (ru) |
| MX (1) | MXPA04010315A (ru) |
| MY (1) | MY139228A (ru) |
| NO (1) | NO20044531L (ru) |
| NZ (1) | NZ535823A (ru) |
| PA (1) | PA8571401A1 (ru) |
| PE (1) | PE20040172A1 (ru) |
| PL (1) | PL373322A1 (ru) |
| RU (1) | RU2318814C2 (ru) |
| TW (1) | TW200306807A (ru) |
| UY (1) | UY27770A1 (ru) |
| WO (1) | WO2003091236A1 (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1296365C (zh) * | 2002-04-23 | 2007-01-24 | 弗·哈夫曼-拉罗切有限公司 | 咪唑啉基甲基芳烷基磺酰胺 |
| US20070149606A1 (en) * | 2003-12-26 | 2007-06-28 | Daiichi Pharmaceutical Co.,Ltd. | Process for producing phenylacetic acid derivative |
| WO2009100120A2 (en) | 2008-02-04 | 2009-08-13 | Neurogen Corporation | Pyridinyl-substituted piperazinyl oxoethyl tetrahydropyrazolopyridines |
| MX2010007929A (es) * | 2008-02-04 | 2010-08-09 | Hoffmann La Roche | Imidazolinilmetil aril sulfonamidas novedosas. |
| JP2011511025A (ja) * | 2008-02-04 | 2011-04-07 | エフ．ホフマン−ラ ロシュ アーゲー | 新規イミダゾリニルメチルアリールスルホンアミド |
| AU2009211503A1 (en) * | 2008-02-04 | 2009-08-13 | F. Hoffmann-La Roche Ag | Novel imidazolinylmethyl aryl sulfonamides |
| EP2238113A1 (en) * | 2008-02-04 | 2010-10-13 | F. Hoffmann-La Roche AG | N-[3-bromo-2-chloro-4-(4, 5-dihydro-1h-imidazol-2-ylmethyl)-phenyl] -methanesulfoamide as alpha-1 a adrenergic partial agonist for the treatment of incontinence |
| JP4168086B1 (ja) * | 2008-04-16 | 2008-10-22 | 国立大学法人福井大学 | イミダゾリン誘導体 |
| CN103664845B (zh) * | 2013-12-27 | 2016-02-10 | 湖南欧亚生物有限公司 | 一种Plk激酶抑制剂药物中间体7-氨基-2,3-二氢苯并呋喃-4-甲酸的制备方法 |
| CN103853429B (zh) * | 2014-03-14 | 2018-01-23 | 联想(北京)有限公司 | 信息处理方法、信息处理装置及电子设备 |
| CN105693524A (zh) * | 2014-11-28 | 2016-06-22 | 浙江省化工研究院有限公司 | 一种硝基化合物的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3660423A (en) * | 1970-02-13 | 1972-05-02 | Dow Chemical Co | 2-(substituted benzyl)methyl-2-imidazolines |
| AU3115471A (en) | 1970-07-22 | 1973-01-18 | Merck & Co Inc | Chemical processes and products |
| SG72827A1 (en) * | 1997-06-23 | 2000-05-23 | Hoffmann La Roche | Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
| TW405272B (en) | 1997-06-25 | 2000-09-11 | Sony Corp | Method and apparatus for growth of a nitride III-V compound semiconductor |
| GB9910110D0 (en) * | 1999-04-30 | 1999-06-30 | Glaxo Group Ltd | Chemical compounds |
| US6323231B1 (en) * | 2000-02-17 | 2001-11-27 | Abbott Laboratories | Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence |
| US6602897B2 (en) | 2000-10-14 | 2003-08-05 | Boehringer Ingelheim Pharma Kg | m-Amino-phenylimino-imidazolidine derivatives for treating urinary incontinence |
| US20020169193A1 (en) | 2001-02-10 | 2002-11-14 | Pascale Pouzet | Alkylphenyliminoimidazolidine derivatives for treating urinary incontinence |
| CN1296365C (zh) * | 2002-04-23 | 2007-01-24 | 弗·哈夫曼-拉罗切有限公司 | 咪唑啉基甲基芳烷基磺酰胺 |
-
2003
- 2003-04-15 CN CNB038089238A patent/CN1296365C/zh not_active Expired - Fee Related
- 2003-04-15 BR BR0309668-8A patent/BR0309668A/pt not_active IP Right Cessation
- 2003-04-15 AU AU2003227623A patent/AU2003227623B2/en not_active Ceased
- 2003-04-15 WO PCT/EP2003/003904 patent/WO2003091236A1/en active Application Filing
- 2003-04-15 CA CA2483345A patent/CA2483345C/en not_active Expired - Fee Related
- 2003-04-15 MX MXPA04010315A patent/MXPA04010315A/es active IP Right Grant
- 2003-04-15 PL PL03373322A patent/PL373322A1/xx not_active Application Discontinuation
- 2003-04-15 JP JP2003587796A patent/JP4362379B2/ja not_active Expired - Fee Related
- 2003-04-15 NZ NZ535823A patent/NZ535823A/en not_active IP Right Cessation
- 2003-04-15 KR KR1020047016958A patent/KR100696561B1/ko not_active IP Right Cessation
- 2003-04-15 RU RU2004134326/04A patent/RU2318814C2/ru not_active IP Right Cessation
- 2003-04-15 EP EP03725029A patent/EP1501817A1/en not_active Withdrawn
- 2003-04-16 TW TW092108802A patent/TW200306807A/zh unknown
- 2003-04-16 PE PE2003000388A patent/PE20040172A1/es not_active Application Discontinuation
- 2003-04-21 AR ARP030101352A patent/AR039319A1/es unknown
- 2003-04-21 PA PA20038571401A patent/PA8571401A1/es unknown
- 2003-04-22 MY MYPI20031496A patent/MY139228A/en unknown
- 2003-04-22 UY UY27770A patent/UY27770A1/es not_active Application Discontinuation
- 2003-04-22 US US10/421,119 patent/US6756395B2/en not_active Expired - Fee Related
-
2004
- 2004-04-13 US US10/823,012 patent/US7407980B2/en not_active Expired - Fee Related
- 2004-10-12 HR HR20040951A patent/HRP20040951A2/hr not_active Application Discontinuation
- 2004-10-18 IL IL16467604A patent/IL164676A0/xx unknown
- 2004-10-21 NO NO20044531A patent/NO20044531L/no not_active Application Discontinuation
-
2006
- 2006-01-05 HK HK06100195A patent/HK1080463A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005534628A (ja) | 2005-11-17 |
| TW200306807A (en) | 2003-12-01 |
| US20030229130A1 (en) | 2003-12-11 |
| PL373322A1 (en) | 2005-08-22 |
| RU2318814C2 (ru) | 2008-03-10 |
| AU2003227623A1 (en) | 2003-11-10 |
| US7407980B2 (en) | 2008-08-05 |
| HRP20040951A2 (hr) | 2006-06-30 |
| MXPA04010315A (es) | 2005-06-08 |
| JP4362379B2 (ja) | 2009-11-11 |
| US6756395B2 (en) | 2004-06-29 |
| CN1296365C (zh) | 2007-01-24 |
| US20040214875A1 (en) | 2004-10-28 |
| KR20040102151A (ko) | 2004-12-03 |
| CN1646516A (zh) | 2005-07-27 |
| AU2003227623B2 (en) | 2010-05-20 |
| NZ535823A (en) | 2007-07-27 |
| AR039319A1 (es) | 2005-02-16 |
| MY139228A (en) | 2009-08-28 |
| KR100696561B1 (ko) | 2007-03-19 |
| CA2483345C (en) | 2010-12-21 |
| WO2003091236A1 (en) | 2003-11-06 |
| UY27770A1 (es) | 2003-10-31 |
| RU2004134326A (ru) | 2006-01-27 |
| PA8571401A1 (es) | 2004-02-07 |
| HK1080463A1 (en) | 2006-04-28 |
| IL164676A0 (en) | 2005-12-18 |
| CA2483345A1 (en) | 2003-11-06 |
| PE20040172A1 (es) | 2004-04-08 |
| BR0309668A (pt) | 2005-03-01 |
| EP1501817A1 (en) | 2005-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0022438D0 (en) | Organic Compounds | |
| TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
| NO20064078L (no) | Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter | |
| MXPA04005156A (es) | Antagonistas del receptor de adenosina a2a. | |
| NO20051962L (no) | Fenetanolaminderivater for behandling av respiratoriske sykdommer | |
| DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| TW200637828A (en) | Novel cis-imidazolines | |
| UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
| NO20065904L (no) | Terapeutiske forbindelser | |
| MX2007011009A (es) | Compuestos de piperidina 3,4,5-substituidos. | |
| UA83233C2 (ru) | Замещенный 2-аминотетралин для лечения депрессии | |
| MXPA04005209A (es) | Antagonistas del receptor de adenosina a2a. | |
| NO330888B1 (no) | Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom | |
| NO20070570L (no) | Forbindelser. | |
| WO2006074924A8 (en) | 3,4,(5)-substituted tetrahvdropyridines | |
| GB0428250D0 (en) | Organic compounds | |
| NO20044531L (no) | Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom | |
| WO2002092072A3 (en) | Drugs for the treatment of the alzheimer disease | |
| MXPA05005790A (es) | Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central. | |
| SE0303480D0 (sv) | Benzofuranes | |
| TW200634002A (en) | Chemical compounds | |
| ID29025A (id) | Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya | |
| AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
| TW200716618A (en) | Chemical compounds | |
| ATE391710T1 (de) | Substituierte azetidinverbindungen als cyclooxigenase-1-cyclooxygenase-2-inhibitoren und deren herstellung und verwendung als medikament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application | ||
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |